Guarantor Non-Guarantor Subsidiary Financial Information Level 3 (Tables)

12 Months Ended

Dec. 31, 2012

Guarantor - Condensed Consolidating Statements of Operations [Abstract]

Condensed Consolidating Balance Sheet [Table Text Block]

MOMENTIVE SPECIALTY CHEMICALS INC.

CONDENSED CONSOLIDATING BALANCE SHEET

DECEMBER 31, 2012

	Momentive Specialty Chemicals Inc.			Subsidiary Issuers		Combined Subsidiary Guarantors			Combined Non-Guarantor Subsidiaries			Eliminations			Consolidated
Assets
Current assets
Cash and cash equivalents (including restricted cash of $0 and $18, respectively)	$	276		$	—	$	—		$	143		$	—		$	419
Short-term investments	—			—		—			5			—			5
Accounts receivable, net	177			—		—			350			—			527
Intercompany accounts receivable	126			52		—			318			(496		)	—
Intercompany loans receivable - current portion	162			—		—			624			(786		)	—
Inventories:
Finished and in-process goods	109			—		—			153			—			262
Raw materials and supplies	35			—		—			70			—			105
Other current assets	38			—		—			43			—			81
Total current assets	923			52		—			1,706			(1,282		)	1,399
Investment in unconsolidated entities	252			—		42			18			(270		)	42
Deferred income taxes	337			—		—			11			—			348
Other assets, net	—			42		28			39			—			109
Intercompany loans receivable	773			2,273		27			3,835			(6,908		)	—
Property and equipment, net	493			—		—			674			—			1,167
Goodwill	93			—		—			76			—			169
Other intangible assets, net	53			—		—			38			—			91
Total assets	$	2,924		$	2,367	$	97		$	6,397		$	(8,460	)	$	3,325
Liabilities and (Deficit) Equity
Current liabilities
Accounts payable	$	136		$	—	$	—		$	282		$	—		$	418
Intercompany accounts payable	96			4		1			395			(496		)	—
Debt payable within one year	13			—		—			63			—			76
Intercompany loans payable within one year	197			—		—			589			(786		)	—
Interest payable	12			51		—			—			—			63
Income taxes payable	3			—		—			1			—			4
Accrued payroll and incentive compensation	14			—		—			26			—			40
Other current liabilities	64			—		—			65			—			129
Total current liabilities	535			55		1			1,421			(1,282		)	730
Long-term debt	860			2,138		—			421			—			3,419
Intercompany loans payable	2,303			4		7			4,594			(6,908		)	—
Accumulated losses of unconsolidated subsidiaries in excess of investment	325			—		107			—			(432		)	—
Long-term pension and post employment benefit obligations	98			—		—			211			—			309
Deferred income taxes	—			1		—			17			—			18
Other long-term liabilities	120			6		—			40			—			166
Total liabilities	4,241			2,204		115			6,704			(8,622		)	4,642
Total Momentive Specialty Chemicals Inc. shareholders (deficit) equity	(1,317		)	163		(18		)	(307		)	162			(1,317		)
Noncontrolling interest	—			—		—			—			—			—
Total (deficit) equity	(1,317		)	163		(18		)	(307		)	162			(1,317		)
Total liabilities and (deficit) equity	$	2,924		$	2,367	$	97		$	6,397		$	(8,460	)	$	3,325

MOMENTIVE SPECIALTY CHEMICALS INC.

CONDENSED CONSOLIDATING BALANCE SHEET

DECEMBER 31, 2011

	Momentive Specialty Chemicals Inc.			Subsidiary Issuers		Combined Subsidiary Guarantors		Combined Non-Guarantor Subsidiaries			Eliminations			Consolidated
Assets
Current assets
Cash and cash equivalents (including restricted cash of $0 and $3, respectively)	$	212		$	—	$	—	$	207		$	—		$	419
Short-term investments	—			—		—		7			—			7
Accounts receivable, net	206			—		—		386			—			592
Intercompany accounts receivable	102			46		—		257			(405		)	—
Intercompany loans receivable - current portion	203			—		—		713			(916		)	—
Inventories:
Finished and in-process goods	116			—		—		138			—			254
Raw materials and supplies	33			—		—		70			—			103
Other current assets	27			—		—		45			—			72
Total current assets	899			46		—		1,823			(1,321		)	1,447
Investment in unconsolidated entities	288			—		20		13			(295		)	26
Deferred income taxes	—			—		—		4			—			4
Other assets, net	11			36		20		72			—			139
Intercompany loans receivable	649			1,907		22		4,592			(7,170		)	—
Property and equipment, net	504			—		—		705			—			1,209
Goodwill	93			—		—		74			—			167
Other intangible assets, net	59			—		—		45			—			104
Total assets	$	2,503		$	1,989	$	62	$	7,328		$	(8,786	)	$	3,096
Liabilities and (Deficit) Equity
Current liabilities
Accounts payable	$	125		$	—	$	—	$	256		$	—		$	381
Intercompany accounts payable	78			4		1		322			(405		)	—
Debt payable within one year	17			—		—		100			—			117
Intercompany loans payable within one year	238			—		—		678			(916		)	—
Affiliated debt payable within one year	2			—		—		—			—			2
Interest payable	14			44		—		3			—			61
Income taxes payable	1			—		—		14			—			15
Accrued payroll and incentive compensation	26			—		—		31			—			57
Other current liabilities	69			—		—		63			—			132
Total current liabilities	570			48		1		1,467			(1,321		)	765
Long-term debt	1,134			1,688		—		598			—			3,420
Intercompany loans payable	1,903			4		6		5,257			(7,170		)	—
Accumulated losses of unconsolidated subsidiaries in excess of investment	192			—		—		—			(192		)	—
Long-term pension and post employment benefit obligations	99			—		—		124			—			223
Deferred income taxes	30			2		—		40			—			72
Other long-term liabilities	116			6		—		34			—			156
Advance from affiliates	225			—		—		—			—			225
Total liabilities	4,269			1,748		7		7,520			(8,683		)	4,861
Total Momentive Specialty Chemicals Inc. shareholders (deficit) equity	(1,766		)	241		55		(193		)	(103		)	(1,766		)
Noncontrolling interest	—			—		—		1			—			1
Total (deficit) equity	(1,766		)	241		55		(192		)	(103		)	(1,765		)
Total liabilities and (deficit) equity	$	2,503		$	1,989	$	62	$	7,328		$	(8,786	)	$	3,096

Condensed Consolidating Statement of Operations [Table Text Block]

MOMENTIVE SPECIALTY CHEMICALS INC.

CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS

YEAR ENDED DECEMBER 31, 2012

	Momentive Specialty Chemicals Inc.			Subsidiary Issuers			Combined Subsidiary Guarantors			Combined Non-Guarantor Subsidiaries			Eliminations			Consolidated
Net sales	$	2,120		$	—		$	—		$	2,902		$	(266	)	$	4,756
Cost of sales	1,800			—			—			2,626			(266		)	4,160
Gross profit	320			—			—			276			—			596
Selling, general and administrative expense	61			—			—			261			—			322
Asset impairments	—			—			—			23			—			23
Business realignment costs	9			—			—			26			—			35
Other operating expense (income), net	6			2			(1		)	7			—			14
Operating income (loss)	244			(2		)	1			(41		)	—			202
Interest expense, net	59			176			—			28			—			263
Intercompany interest expense (income)	132			(186		)	(1		)	55			—			—
Other non-operating (income) expense, net	(8		)	(2		)	—			9			—			(1		)
Income (loss) from continuing operations before income tax, earnings from unconsolidated entities	61			10			2			(133		)	—			(60		)
Income tax (benefit) expense	(371		)	—			—			6			—			(365		)
Income (loss) from continuing operations before earnings from unconsolidated entities	432			10			2			(139		)	—			305
(Losses) earnings from unconsolidated entities, net of taxes	(108		)	—			(71		)	3			195			19
Net income (loss)	$	324		$	10		$	(69	)	$	(136	)	$	195		$	324
Comprehensive income (loss) attributable to Momentive Specialty Chemicals Inc.	$	230		$	13		$	(69	)	$	(229	)	$	285		$	230

MOMENTIVE SPECIALTY CHEMICALS INC.

CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS

YEAR ENDED DECEMBER 31, 2011

	Momentive Specialty Chemicals Inc.			Subsidiary Issuers			Combined Subsidiary Guarantors			Combined Non-Guarantor Subsidiaries			Eliminations			Consolidated
Net sales	$	2,246		$	—		$	—		$	3,254		$	(293	)	$	5,207
Cost of sales	1,856			—			—			2,910			(293		)	4,473
Gross profit	390			—			—			344			—			734
Selling, general and administrative expense	110			—			—			225			—			335
Asset impairments	4			—			—			28			—			32
Business realignment costs	2			—			—			13			—			15
Other operating (income) expense, net	(20		)	—			(1		)	5			—			(16		)
Operating income	294			—			1			73			—			368
Interest expense, net	69			150			—			43			—			262
Intercompany interest expense (income)	121			(170		)	(1		)	50			—			—
Other non-operating expense (income), net	8			—			—			(5		)	—			3
Income (loss) from continuing operations before income tax, earnings from unconsolidated entities	96			20			2			(15		)	—			103
Income tax (benefit) expense	(8		)	1			—			10			—			3
Income (loss) from continuing operations before earnings from unconsolidated entities	104			19			2			(25		)	—			100
Earnings from unconsolidated entities, net of taxes	32			—			22			1			(39		)	16
Net income (loss) from continuing operations	136			19			24			(24		)	(39		)	116
Net (loss) income from discontinued operations	(18		)	—			—			20			—			2
Net income (loss)	$	118		$	19		$	24		$	(4	)	$	(39	)	$	118
Comprehensive income (loss) attributable to Momentive Specialty Chemicals Inc.	$	47		$	20		$	23		$	(19	)	$	(24	)	$	47

MOMENTIVE SPECIALTY CHEMICALS INC.

CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS

YEAR ENDED DECEMBER 31, 2010

	Momentive Specialty Chemicals Inc.			Subsidiary Issuers			Combined Subsidiary Guarantors			Combined Non-Guarantor Subsidiaries			Eliminations			Consolidated
Net sales	$	2,002		$	—		$	—		$	2,934		$	(339	)	$	4,597
Cost of sales	1,618			—			—			2,587			(339		)	3,866
Gross profit	384			—			—			347			—			731
Selling, general and administrative expense	117			—			—			215			—			332
Terminated merger and settlement income, net	(171		)	—			—			—			—			(171		)
Business realignment costs	5			—			—			15			—			20
Other operating expense (income), net	6			—			—			(2		)	—			4
Operating income	427			—			—			119			—			546
Interest expense, net	92			144			—			40			—			276
Loss on extinguishment of debt	7			5			—			18			—			30
Intercompany interest expense (income)	123			(169		)	(1		)	47			—			—
Other non-operating (income) expense, net	(18		)	8			—			6			—			(4		)
Income from continuing operations before income tax, earnings from unconsolidated entities	223			12			1			8			—			244
Income tax (benefit) expense	(11		)	10			—			36			—			35
Income (loss) from continuing operations before earnings from unconsolidated entities	234			2			1			(28		)	—			209
(Losses) earnings from unconsolidated entities, net of taxes	(13		)	—			(5		)	—			26			8
Net income (loss) from continuing operations	221			2			(4		)	(28		)	26			217
Net (loss) income from discontinued operations, net of tax	(7		)	—			—			4			—			(3		)
Net income (loss)	$	214		$	2		$	(4	)	$	(24	)	$	26		$	214
Comprehensive income (loss) attributable to Momentive Specialty Chemicals Inc.	$	203		$	24		$	(4	)	$	(71	)	$	51		$	203

Condensed Consolidating Statement of Cash Flows [Table Text Block]

MOMENTIVE SPECIALTY CHEMICALS INC.

CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS

YEAR ENDED DECEMBER 31, 2012

	Momentive Specialty Chemicals Inc.			Subsidiary Issuers			Combined Subsidiary Guarantors			Combined Non-Guarantor Subsidiaries			Eliminations			Consolidated
Cash flows provided by (used in) operating activities	$	88		$	(59	)	$	16		$	160		$	(28	)	$	177
Cash flows provided by (used in) investing activities
Capital expenditures	(57		)	—			—			(76		)	—			(133		)
Proceeds from sale of debt securities, net	—			—			—			2			—			2
Change in restricted cash	—			—			—			(15		)	—			(15		)
Funds remitted to unconsolidated affiliates, net	—			—			—			(3		)	—			(3		)
Proceeds from sale of assets	9			—			—			2			—			11
Capital contribution to subsidiary	(30		)	—			(19		)	—			49			—
Return of capital from subsidiary from sales of accounts receivable	87			—			—			—			(87		)	—
	9			—			(19		)	(90		)	(38		)	(138		)
Cash flows (used in) provided by financing activities
Net short-term debt repayments	—			—			—			(7		)	—			(7		)
Borrowings of long-term debt	—			450			—			3			—			453
Repayments of long-term debt	(278		)	—			—			(209		)	—			(487		)
Repayment of affiliated debt	(2		)	—			—			—			—			(2		)
Repayment of advance from affiliates	(7		)	—			—			—			—			(7		)
Net intercompany loan borrowings (repayments)	251			(364		)	(3		)	116			—			—
Capital contribution from parent	16			—			19			30			(49		)	16
Long-term debt and credit facility financing fees	(2		)	(12		)	—			—			—			(14		)
Common stock dividends paid	(11		)	(15		)	(13		)	—			28			(11		)
Return of capital to parent from sales of accounts receivable	—			—			—			(87		)	87			—
	(33		)	59			3			(154		)	66			(59		)
Effect of exchange rates on cash and cash equivalents	—			—			—			5			—			5
Increase (decrease) in cash and cash equivalents	64			—			—			(79		)	—			(15		)
Cash and cash equivalents (unrestricted) at beginning of year	212			—			—			204			—			416
Cash and cash equivalents (unrestricted) at end of year	$	276		$	—		$	—		$	125		$	—		$	401

MOMENTIVE SPECIALTY CHEMICALS INC.

CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS

YEAR ENDED DECEMBER 31, 2011

	Momentive Specialty Chemicals Inc.			Subsidiary Issuers			Combined Subsidiary Guarantors			Combined Non-Guarantor Subsidiaries			Eliminations			Consolidated
Cash flows (used in) provided by operating activities	$	(41	)	$	8		$	31		$	198		$	(25	)	$	171
Cash flows provided by (used in) investing activities
Capital expenditures	(74		)	—			—			(65		)	—			(139		)
Capitalized interest	(1		)	—			—			—			—			(1		)
Purchases of debt securities, net	—			—			—			(2		)	—			(2		)
Change in restricted cash	—			—			—			3			—			3
Funds remitted to unconsolidated affiliates, net	—			—			—			(4		)	—			(4		)
Proceeds from sale of business, net of cash transferred	49			—			—			124			—			173
Proceeds from sale of assets	2			—			—			1			—			3
Capital contribution to subsidiary	(11		)	—			(19		)	—			30			—
Return of capital from subsidiary	47			—			—			—			(47		)	—
Return of capital from subsidiary from sales of accounts receivable	69			—			—			—			(69		)	—
	81			—			(19		)	57			(86		)	33
Cash flows provided by (used in) financing activities
Net short-term debt (repayments) borrowings	(7		)	—			—			21			—			14
Borrowings of long-term debt	164			—			—			332			—			496
Repayments of long-term debt	(182		)	—			—			(356		)	—			(538		)
Repayment of advance from affiliate	(80		)	—			—			(20		)	—			(100		)
Net intercompany loan borrowings (repayments)	51			4			—			(55		)	—			—
Capital contribution from parent	189			—			—			30			(30		)	189
Long-term debt and credit facility financing fees	(2		)	—			—			—			—			(2		)
Common stock dividends paid	(2		)	(12		)	(12		)	(1		)	25			(2		)
Return of capital to parent	—			—			—			(47		)	47			—
Return of capital to parent from sales of accounts receivable	—			—			—			(69		)	69			—
	131			(8		)	(12		)	(165		)	111			57
Effect of exchange rates on cash and cash equivalents	—			—			—			(5		)	—			(5		)
Increase in cash and cash equivalents	171			—			—			85			—			256
Cash and cash equivalents (unrestricted) at beginning of year	41			—			—			119			—			160
Cash and cash equivalents (unrestricted) at end of year	$	212		$	—		$	—		$	204		$	—		$	416

MOMENTIVE SPECIALTY CHEMICALS INC.

CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS

YEAR ENDED DECEMBER 31, 2010

	Momentive Specialty Chemicals Inc.			Subsidiary Issuers			Combined Subsidiary Guarantors			Combined Non-Guarantor Subsidiaries			Eliminations			Consolidated
Cash flows (used in) provided by operating activities	$	(444	)	$	19		$	5		$	490		$	(19	)	$	51
Cash flows provided by (used in) investing activities
Capital expenditures	(52		)	—			—			(67		)	—			(119		)
Capitalized interest	—			—			—			(1		)	—			(1		)
Proceeds from sale of debt securities, net	—			—			—			4			—			4
Change in restricted cash	—			—			—			2			—			2
Deconsolidation of variable interest entities	—			—			—			(4		)	—			(4		)
Funds remitted to unconsolidated affiliates, net	—			—			—			(1		)	—			(1		)
Proceeds from sale of assets	6			—			—			8			—			14
Return of capital from subsidiary from sales of accounts receivable	367			—			—			—			(367		)	—
	321			—			—			(59		)	(367		)	(105		)
Cash flows provided by (used in) financing activities
Net short-term debt borrowings (repayments)	3			—			—			(10		)	—			(7		)
Borrowings of long-term debt	290			1,433			—			633			—			2,356
Repayments of long-term debt	(1,108		)	(406		)	—			(663		)	—			(2,177		)
Repayments of affiliated debt	(3		)	—			—			—			—			(3		)
Net intercompany loan borrowings (repayments)	987			(973		)	—			(14		)	—			—
Long-term debt and credit facility financing fees	(9		)	(63		)	—			—			—			(72		)
Common stock dividends paid	—			(10		)	(5		)	(4		)	19			—
Return of capital to parent from sales of accounts receivable	—			—			—			(367		)	367			—
	160			(19		)	(5		)	(425		)	386			97
Effect of exchange rates on cash and cash equivalents	—			—			—			2			—			2
Increase in cash and cash equivalents	37			—			—			8			—			45
Cash and cash equivalents (unrestricted) at beginning of year	4			—			—			111			—			115
Cash and cash equivalents (unrestricted) at end of year	$	41		$	—		$	—		$	119		$	—		$	160